Compass Therapeutics, Inc. Profile Avatar - Palmy Investing

Compass Therapeutics, Inc.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-…

Biotechnology
US, Boston [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of CMPX's Analysis
CIK: 1738021 CUSIP: 20454B104 ISIN: US20454B1044 LEI: - UEI: -
Secondary Listings
CMPX has no secondary listings inside our databases.